Evaluating Quadratus Lumborum Block for Reducing Pain After Laparoscopic Myomectomy Surgery in Women Aged 18 to 45

What this Trial Is About

Researchers are evaluating the use of a quadratus lumborum QL block to reduce postoperative pain in women undergoing laparoscopic myomectomy for uterine fibroids. The study is a phase 4, double-blinded, randomized clinical trial comparing patients who receive the QL block with bupivacaine to those who receive a sham saline injection, alongside standard anesthesia and postoperative pain care. The goal is to determine if the QL block can improve pain management after surgery. Participants are randomly assigned to one of two groups one group receives a QL block with a total of 60cc bupivacaine injected bilaterally into the quadratus lumborum muscles, while the other group receives a sham injection of 60cc saline in the same muscles. Both injections are given as part of the anesthesia during surgery. This study lasts up to 48 hours after hospital discharge for follow-up pain and satisfaction assessments. During the study, researchers will monitor the time from surgery until the first request for pain relief and count the total doses of rescue pain medication given within 24 hours. Pain levels will be measured using a visual analog scale VAS for up to 48 hours after discharge, along with patient satisfaction ratings on a scale of 1 to 10. Participants will be observed closely during this period to assess the impact of the QL block on postoperative pain control and overall experience.

QL Block in Laparoscopic Myomectomy